Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study

Purpose: The study aims to retrospectively investigate the efficacy and safety of sorafenib combined with transarterial chemoembolization (TACE) (TACE+Sor) vs. TACE combined with sorafenib plus immune checkpoint inhibitors (TACE+Sor+ICIs) in treating intermediate and advanced TACE-refractory hepatoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Liyun, Fang, Shiji, Wu, Fazong, Chen, Weiqian, Chen, Minjiang, Weng, Qiaoyou, Wu, Xulu, Song, Jingjing, Zhao, Zhongwei, Ji, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843459/
https://www.ncbi.nlm.nih.gov/pubmed/33521054
http://dx.doi.org/10.3389/fmolb.2020.609322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843459/
https://www.ncbi.nlm.nih.gov/pubmed/33521054
http://dx.doi.org/10.3389/fmolb.2020.609322

Ejemplares similares